72 related articles for article (PubMed ID: 11366728)
21. Nevirapine, prednisone and rash.
Proj Inf Perspect; 2000 Oct; (31):6. PubMed ID: 12171021
[TBL] [Abstract][Full Text] [Related]
22. Toxic epidermal necrolysis induced by nevirapine therapy: description of two cases and review of the literature.
Cattelan AM; Trevenzoli M; Sasset L; Sgarabotto D; Lanzafame M; Meneghetti F
J Infect; 2001 Nov; 43(4):246-9. PubMed ID: 11869062
[TBL] [Abstract][Full Text] [Related]
23. A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load.
Arranz Caso JA; López JC; Santos I; Estrada V; Castilla V; Sanz J; Sanz J; Molina JP; Fernández Guerrero M; Górgolas M
HIV Med; 2005 Sep; 6(5):353-9. PubMed ID: 16156884
[TBL] [Abstract][Full Text] [Related]
24. Optimal treatment of nevirapine-associated hepatotoxicity remains uncertain.
Bundow D; Rosoff L; Aboulafia DM
AIDS Read; 2001 Nov; 11(11):577-80. PubMed ID: 11789021
[TBL] [Abstract][Full Text] [Related]
25. [Reliable effectiveness for years with good long-term tolerance: 10 years nevirapine--a summary].
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():70. PubMed ID: 19024921
[No Abstract] [Full Text] [Related]
26. Nevirapine-related adverse events in a patient receiving a fixed-drug combination pill.
Daniel OJ; Krain AB; Ogun SA; Odusoga OL; Boyle BA
J Natl Med Assoc; 2005 Dec; 97(12):1719-21. PubMed ID: 16396066
[TBL] [Abstract][Full Text] [Related]
27. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
Kravchenko AV
Ter Arkh; 2004; 76(11):68-71. PubMed ID: 15658542
[No Abstract] [Full Text] [Related]
28. [Reliability: nevirapine. Highly effective + favorable influence on lipid profile].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():42-3. PubMed ID: 16385872
[No Abstract] [Full Text] [Related]
29. [Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():58-60. PubMed ID: 15373051
[No Abstract] [Full Text] [Related]
30. Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
Koh MT
Int J Infect Dis; 2007 Jan; 11(1):85-6. PubMed ID: 16581278
[No Abstract] [Full Text] [Related]
31. Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy.
Antinori A; Baldini F; Girardi E; Cingolani A; Zaccarelli M; Di Giambenedetto S; Barracchini A; De Longis P; Murri R; Tozzi V; Ammassari A; Rizzo MG; Ippolito G; De Luca A
AIDS; 2001 Aug; 15(12):1579-81. PubMed ID: 11504993
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for nevirapine-associated rash among HIV-infected patients with low CD4 cell counts in resource-limited settings.
Kiertiburanakul S; Sungkanuparph S; Charoenyingwattana A; Mahasirimongkol S; Sura T; Chantratita W
Curr HIV Res; 2008 Jan; 6(1):65-9. PubMed ID: 18288977
[TBL] [Abstract][Full Text] [Related]
33. Frequency of cutaneous reactions on rechallenge with nevirapine and delavirdine.
Gangar M; Arias G; O'Brien JG; Kemper CA
Ann Pharmacother; 2000; 34(7-8):839-42. PubMed ID: 10928391
[TBL] [Abstract][Full Text] [Related]
34. [Toxic epidermal necrolysis in relation with nevirapine].
Vera Méndez FJ; Martínez Madrid OJ; García Henarejos JA; García Solano J; Vilaplana García R
An Med Interna; 2000 Aug; 17(8):448-9. PubMed ID: 11218998
[No Abstract] [Full Text] [Related]
35. Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS).
Gill S; Sagar A; Shankar S; Nair V
Indian J Pharmacol; 2013; 45(4):401-2. PubMed ID: 24014920
[TBL] [Abstract][Full Text] [Related]
36. Death halts study.
Posit Aware; 2000; 11(1):23. PubMed ID: 11366339
[TBL] [Abstract][Full Text] [Related]
37. Delavirdine levels in women.
Vazquez E
Posit Aware; 1997; 8(4):14. PubMed ID: 11364481
[TBL] [Abstract][Full Text] [Related]
38. Nevirapine-induced hepatitis treated with corticosteroids?
Leitze Z; Nadeem A; Choudhary A; Saul Z; Roberts I; Manthous CA
AIDS; 1998 Jun; 12(9):1115-7. PubMed ID: 9662216
[No Abstract] [Full Text] [Related]
39. Drug-specific T cells in an HIV-positive patient with nevirapine-induced hepatitis.
Drummond NS; Vilar FJ; Naisbitt DJ; Hanson A; Woods A; Park BK; Pirmohamed M
Antivir Ther; 2006; 11(3):393-5. PubMed ID: 16759058
[TBL] [Abstract][Full Text] [Related]
40. Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts.
Martin AM; Nolan D; James I; Cameron P; Keller J; Moore C; Phillips E; Christiansen FT; Mallal S
AIDS; 2005 Jan; 19(1):97-9. PubMed ID: 15627041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
